How To Use HCPCS Code C1779

HCPCS code C1779 describes a lead used in a transvenous VDD single pass pacemaker. This code is used to identify the specific type of lead used in the pacemaker procedure. In this article, we will explore the details of HCPCS code C1779, including its official description, procedure, when to use it, billing guidelines, historical information, Medicare and insurance coverage, and provide examples of when this code should be billed.

1. What is HCPCS C1779?

HCPCS code C1779 is used to identify the lead used in a transvenous VDD single pass pacemaker. This code specifically refers to the parenteral supply used in the procedure. It is important to note that this code is not applicable for other types of pacemakers or procedures.

2. Official Description

The official description of HCPCS code C1779 is “Lead, pacemaker, transvenous VDD single pass.” This description accurately represents the specific lead used in the transvenous VDD single pass pacemaker procedure. The short description for this code is “Parenteral supp not othrws c,” indicating that it is a parenteral supply that is not otherwise classified.

3. Procedure

1. The provider begins the procedure by accessing the patient’s venous system.
2. A lead, specifically the lead identified by HCPCS code C1779, is inserted into the venous system and guided to the desired location within the heart.
3. The lead is then connected to the pacemaker device, completing the transvenous VDD single pass pacemaker implantation.

4. When to use HCPCS code C1779

HCPCS code C1779 should be used when performing a transvenous VDD single pass pacemaker procedure and specifically using the lead identified by this code. It is important to ensure that the procedure and the specific lead meet the criteria outlined in the official description of the code.

5. Billing Guidelines and Documentation Requirements

When billing for HCPCS code C1779, healthcare providers should ensure that the procedure and the use of the specific lead are clearly documented in the medical record. This documentation should include details such as the type of pacemaker procedure performed, the specific lead used, and any relevant supporting information. Additionally, providers should follow the appropriate billing guidelines and submit the claim with the necessary supporting documentation.

6. Historical Information and Code Maintenance

HCPCS code C1779 was added to the Healthcare Common Procedure Coding System on January 01, 1985. It has an effective date of January 01, 1996. No maintenance actions have been taken for this code, as indicated by the action code N, which means no maintenance for this code. This code has remained unchanged since its addition to the HCPCS.

7. Medicare and Insurance Coverage

Medicare and insurance coverage for HCPCS code C1779 may vary. It is important to consult the Medicare Carriers Manual or the specific insurance provider’s guidelines to determine coverage and reimbursement policies. The pricing indicator code for this code is 57, indicating that it is priced by other carriers. The multiple pricing indicator code is A, indicating that it is not applicable as HCPCS priced under one methodology. Providers should verify coverage and reimbursement rates with the respective payers before submitting claims.

8. Examples

Here are five examples of when HCPCS code C1779 should be billed:

1. A patient undergoes a transvenous VDD single pass pacemaker implantation procedure using the specific lead identified by HCPCS code C1779.
2. A healthcare provider performs a revision surgery on a patient’s existing transvenous VDD single pass pacemaker, replacing the lead with the one specified by HCPCS code C1779.
3. A patient requires a lead replacement due to malfunction or damage, and the specific lead identified by HCPCS code C1779 is used.
4. A transvenous VDD single pass pacemaker procedure is performed on a pediatric patient, utilizing the lead specified by HCPCS code C1779.
5. A patient undergoes a transvenous VDD single pass pacemaker implantation procedure as part of a clinical trial, and the lead used is the one identified by HCPCS code C1779.